Mieloproliferatív neopláziák: vizsgálatok itt: Kanada
21 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07357727 · EU 2025-523555-66-00 - 1. fázisTaking peopleStudy of INCA036978 in Participants With Myeloproliferative Neoplasms
- Where
- Montreal, Toronto
- Életkor
- 18 év and over
- People
- 218 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07441694 · EU 2026-525217-31-00 - 3. fázisTaking peopleA Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Where
- Hamilton, Kingston, Montreal, Québec, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 426 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07623200 · EU 2026-525398-38-00 - 2/3. fázisTaking peopleA Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025).
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 380 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07722611 · EU 2026-525630-38-00 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Montreal
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 2. fázisTaking peopleTesting New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- Where
- Calgary, Edmonton, Greenfield Park, Halifax, Montreal, Ottawa, Toronto, Winnipeg
- Életkor
- 18 év to 59 év
- People
- 335 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05554406 - 3. fázisNot yet taking people in KanadaA Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Where
- Calgary, Hamilton, Lévis, London, Montreal, Toronto
- Életkor
- 18 év and over
- People
- 324 worldwide
- Run by
- Takeda
See details and how to joinNCT07623161 · EU 2026-525660-17-00 - 1. fázisTaking peopleA Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Where
- Calgary, Montreal, Toronto
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06150157 · EU 2023-505584-36-00 - 2. fázisTaking peopleStudy of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
- Where
- Montreal, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 68 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06517875 · EU 2024-518225-15-00 - 2. fázisTaking peopleMYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Where
- Calgary, Edmonton, Greenfield Park, Halifax, Hamilton, Montreal, Ottawa, Toronto, Winnipeg
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05564390 - 1/2. fázisTaking peopleA Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Where
- Calgary, Hamilton, Montreal, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04176198 · EU 2022-502597-16-00 - 2. fázisTaking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Edmonton, Toronto
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
- Életkor
- Up to 25 év
- People
- 75 000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - 2. fázisTaking peopleStudy of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 40
- Run by
- University Health Network, Toronto
See details and how to joinNCT05074355 - 3. fázisBefejeződöttA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - 2. fázisNot yet taking people in KanadaEvaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)
- Where
- Winnipeg
- Életkor
- 18 év and over
- People
- 75
- Run by
- University of Manitoba
See details and how to joinNCT07528417 - 2. fázisTaking peopleEvaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
- Where
- Winnipeg
- Életkor
- 18 év and over
- People
- 75
- Run by
- University of Manitoba
See details and how to joinNCT06599762 - 2. fázisTaking peopleA Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 58 worldwide
- Run by
- Karyopharm Therapeutics Inc
See details and how to joinNCT05980806 - No phaseTaking peopleOURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 60
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT06270771 - No phaseNot yet taking people in KanadaEVAluation of Erythrocytosis PRospEctive Cohort STudy
- Where
- London
- Életkor
- 18 év and over
- People
- 1500
- Run by
- Cyrus Hsia
See details and how to joinNCT06785870 - No phaseTaking peopleMyeloproliferative Neoplasms (MPNs) Patient Registry
- Where
- Toronto
- People
- 5000
- Run by
- University Health Network, Toronto
See details and how to joinNCT02760238